0001493152-20-022146.txt : 20201120
0001493152-20-022146.hdr.sgml : 20201120
20201120180011
ACCESSION NUMBER: 0001493152-20-022146
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201120
FILED AS OF DATE: 20201120
DATE AS OF CHANGE: 20201120
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Rouhandeh Steven H
CENTRAL INDEX KEY: 0001294343
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-15771
FILM NUMBER: 201333692
MAIL ADDRESS:
STREET 1: C/O SCO CAPITAL PARTNERS LLC
STREET 2: 1285 AVENUE OF THE AMERICAS 85TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ABEONA THERAPEUTICS INC.
CENTRAL INDEX KEY: 0000318306
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 830221517
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1330 AVENUE OF THE AMERICAS, 33RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
BUSINESS PHONE: 646-813-4701
MAIL ADDRESS:
STREET 1: 1330 AVENUE OF THE AMERICAS, 33RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
FORMER COMPANY:
FORMER CONFORMED NAME: PLASMATECH BIOPHARMACEUTICALS INC
DATE OF NAME CHANGE: 20140922
FORMER COMPANY:
FORMER CONFORMED NAME: ACCESS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19960209
FORMER COMPANY:
FORMER CONFORMED NAME: CHEMEX PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19920703
4
1
ownership.xml
X0306
4
2020-11-20
0
0000318306
ABEONA THERAPEUTICS INC.
ABEO
0001294343
Rouhandeh Steven H
1330 AVENUE OF THE AMERICAS, 33RD FLOOR
NEW YORK
NY
10019
1
0
1
0
Stock Option (right to buy)
1.28
2020-11-20
4
A
0
86756
A
2030-03-16
Common Stock
86756
86756
D
Stock Option (right to buy)
3.20
2020-11-20
4
D
0
86756
D
2030-03-16
Common Stock
86756
0
D
Stock Option (right to buy)
1.28
2020-11-20
4
A
0
153244
A
2030-03-16
Common Stock
153244
153244
D
Stock Option (right to buy)
1.45
2020-11-20
4
D
0
153244
D
2030-03-16
Common Stock
153244
0
D
Stock Option (right to buy)
1.28
2020-11-20
4
A
0
120000
A
2029-04-09
Common Stock
120000
120000
D
Stock Option (right to buy)
7.24
2020-11-20
4
D
0
120000
D
2029-04-09
Common Stock
120000
0
D
Stock Option (right to buy)
1.28
2020-11-20
4
A
0
120000
A
2027-12-14
Common Stock
120000
120000
D
Stock Option (right to buy)
16.00
2020-11-20
4
D
0
120000
D
2027-12-14
Common Stock
120000
0
D
Stock Option (right to buy)
1.28
2020-11-20
4
A
0
200000
A
2026-12-13
Common Stock
200000
200000
D
Stock Option (right to buy)
4.45
2020-11-20
4
D
0
200000
D
2026-12-13
Common Stock
200000
0
D
Stock Option (right to buy)
1.28
2020-11-20
4
A
0
200000
A
2026-02-11
Common Stock
200000
200000
D
Stock Option (right to buy)
2.31
2020-11-20
4
D
0
200000
D
2026-02-11
Common Stock
200000
0
D
Stock Option (right to buy)
1.28
2020-11-20
4
A
0
125000
A
2025-05-11
Common Stock
125000
125000
D
Stock Option (right to buy)
7.34
2020-11-20
4
D
0
125000
D
2025-05-11
Common Stock
125000
0
D
Stock Option (right to buy)
1.28
2020-11-20
4
A
0
80000
A
2024-03-07
Common Stock
80000
80000
D
Stock Option (right to buy)
18.50
2020-11-20
4
D
0
80000
D
2024-03-07
Common Stock
80000
0
D
The options vest 25% on March 16, 2021, and in 36 equal monthly installments thereafter.
The options granted on May 20, 2020, March 16, 2020, April 9, 2019, December 14, 2017, December 13, 2016, February 11, 2016, May 11, 2015 and March 17, 2014 have each been modified to reflect a lower exercise price.
The options vest 25% on April 9, 2020, and in 36 equal monthly installments thereafter.
The options vest 25% on December 14, 2018, and in 36 equal monthly installments thereafter.
The options vest 25% on December 13, 2017, and in 36 equal monthly installments thereafter.
The options vest 25% on February 11, 2017, and in 36 equal monthly installments thereafter.
The options vest 25% on May 11, 2016, and in 36 equal monthly installments thereafter.
The options vest 25% on March 17, 2015, and in 36 equal monthly installments thereafter.
/s/ Brendan M. O'Malley, as Attorney-in-fact
2020-11-20